Diabetes Education News

High BMI eligibility for semaglutide could cost Medicare up to $145 billion annually, a brief report published in the Annals of Internal Medicine revealed.

A change to hospital policy allowing patients to use their own continuous glucose monitors instead of finger-stick blood glucose monitoring was met favorably by a majority of patients and nurses, according to study findings.

Adults who take semaglutide may have increased risk for developing suicidal thoughts, according to results from a case-control study published in JAMA Network Open.

States that approved caps to limit out-of-pocket costs for insulin did not have increased uptake in insulin use among people with diabetes and commercial insurance, according to findings published in Health Affairs.

A majority of people with diabetes rely on their primary care provider for diabetes management and believe using drugs such as GLP-1 receptor agonists are enough to manage their disease, according to survey results.

Individuals with type 2 diabetes who experience trauma may be at a lower risk for microvascular complications after resolving PTSD symptoms, according to a results from a retrospective study of U.S. veterans published in JAMA Network Open.

A 90-day supply of most of the top generic drugs in the U.S. can be purchased from a discount program for $15 or less, but none of the programs consistently offer the lowest prices for generic drugs, according to two presenters.

Adults with prediabetes and overweight or obesity have a 94% lower risk for developing type 2 diabetes with the once-weekly GIP/GLP-1 dual agonist tirzepatide vs. placebo, according to top-line results from the SURMOUNT-1 3-year study.

A higher intake of heme iron may be linked to an increased risk for developing type 2 diabetes, study results published in Nature Metabolism showed.

Most diabetes care and education specialists said they believe it is important to screen for presymptomatic type 1 diabetes, though some said they had limited knowledge regarding teplizumab-mzwv, according to a presenter.